{
  "CitationSubset": [
    "OM"
  ],
  "KeywordList": [
    [
      "ANXIETY",
      "DEPRESSION",
      "MONOAMINE OXIDASE INHIBITORS"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "13991481",
  "DateCompleted": {
    "Year": "1998",
    "Month": "11",
    "Day": "01"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "12",
    "Day": "01"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "JournalIssue": {
        "Volume": "3(Suppl 1)",
        "PubDate": {
          "Year": "1962",
          "Month": "Aug"
        }
      },
      "Title": "Journal of neuropsychiatry",
      "ISOAbbreviation": "J Neuropsychiatr"
    },
    "ArticleTitle": "The treatment of anxiety states and atypical depressions by the monoamine oxidase inhibitor drugs.",
    "Pagination": {
      "MedlinePgn": "S 96-103"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "SARGANT",
        "ForeName": "W",
        "Initials": "W"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Neuropsychiatr",
    "NlmUniqueID": "0070073"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Monoamine Oxidase Inhibitors"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Anxiety"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Anxiety Disorders"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Depressive Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Monoamine Oxidase Inhibitors"
    }
  ]
}